First Horizon Advisors, Inc. Care Dx, Inc. Transaction History

First Horizon Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $2,569 - $5,124	-291 Reduced 50.79%	282 $2,000
Q4 2022 Feb 10, 2023	BUY	$10.88 - $20.05 $1,795 - $3,308	165 Added 40.44%	573 $6,000
Q3 2022 Nov 09, 2022	SELL	$16.06 - $26.39 $1,718 - $2,823	-107 Reduced 20.78%	408 $7,000
Q2 2022 Aug 02, 2022	BUY	$20.49 - $39.72 $7,130 - $13,822	348 Added 208.38%	515 $11,000
Q1 2022 May 10, 2022	BUY	$28.19 - $46.6 $591 - $978	21 Added 14.38%	167 $6,000
Q4 2021 Feb 09, 2022	SELL	$41.2 - $73.6 $82 - $147	-2 Reduced 1.35%	146 $6,000
Q3 2021 Nov 09, 2021	BUY	$59.15 - $91.99 $118 - $183	2 Added 1.37%	148 $9,000
Q2 2021 Aug 09, 2021	BUY	$63.02 - $95.11 $1,197 - $1,807	19 Added 14.96%	146 $13,000
Q1 2021 May 11, 2021	SELL	$57.62 - $95.6 $576 - $956	-10 Reduced 7.3%	127 $8,000
Q4 2020 Feb 11, 2021	SELL	$41.43 - $77.09 $4,557 - $8,479	-110 Reduced 44.53%	137 $9,000
Q2 2020 Jul 31, 2020	SELL	$18.95 - $35.43 $890 - $1,665	-47 Reduced 15.99%	247 $8,000
Q1 2020 May 05, 2020	BUY	$13.94 - $28.25 $1,505 - $3,051	108 Added 58.06%	294 $6,000
Q3 2019 Oct 23, 2019	BUY	$20.03 - $40.08 $3,725 - $7,454	186 New	186 $4,000

217

53.2M

53.5K

23.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.01B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.